Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o)
- PMID: 8446172
- DOI: 10.1038/362075a0
Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o)
Abstract
The most characteristic change in progressive dementia of Alzheimer's type is a tissue deposit of amyloid beta/A4 protein, which is derived from its precursor protein APP (ref.2). Structural alterations of APP are implicated in the pathogenesis of Alzheimer's disease, but it is not known how they cause the disease. Although APP has a receptor-like architecture, is located on the neuronal surface, and has a conserved cytoplasmic domain, no receptor function has been demonstrated for APP. Here we report that APP forms a complex with G(o), a major GTP-binding protein in brain. The cytoplasmic APP sequence His 657-Lys 676 shows a specific G(o)-activating function and is necessary for complex formation. G(o) protein treated with GTP-gamma S lost the ability to associate with APP. This suggests that APP is a receptor coupled to G(o) and that abnormal APP-G(o) signalling is involved in the Alzheimer's disease process.
Comment in
-
Alzheimer's disease. Amyloid precursor on the G(o).Nature. 1993 Mar 4;362(6415):14-5. doi: 10.1038/362014a0. Nature. 1993. PMID: 8383293 No abstract available.
Similar articles
-
Characterization of the high affinity heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP) and its enhancement by zinc(II).J Mol Recognit. 1995 Jul-Aug;8(4):247-57. doi: 10.1002/jmr.300080403. J Mol Recognit. 1995. PMID: 8588942
-
Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid beta protein precursor.Nat Genet. 1993 Sep;5(1):95-100. doi: 10.1038/ng0993-95. Nat Genet. 1993. PMID: 8220435
-
Intrinsic signaling function of APP as a novel target of three V642 mutations linked to familial Alzheimer's disease.EMBO J. 1996 Aug 1;15(15):3769-77. EMBO J. 1996. PMID: 8670881 Free PMC article.
-
The amyloid peptide precursor in Alzheimer's disease.Acta Neurol Belg. 1995 Dec;95(4):197-209. Acta Neurol Belg. 1995. PMID: 8553793 Review.
-
Cytoplasmic domain of the beta-amyloid protein precursor of Alzheimer's disease: function, regulation of proteolysis, and implications for drug development.J Neurosci Res. 2005 Apr 15;80(2):151-9. doi: 10.1002/jnr.20408. J Neurosci Res. 2005. PMID: 15672415 Review.
Cited by
-
The association of GNB5 with Alzheimer disease revealed by genomic analysis restricted to variants impacting gene function.Am J Hum Genet. 2024 Mar 7;111(3):473-486. doi: 10.1016/j.ajhg.2024.01.005. Epub 2024 Feb 13. Am J Hum Genet. 2024. PMID: 38354736 Free PMC article.
-
Aβ Assemblies Promote Amyloidogenic Processing of APP and Intracellular Accumulation of Aβ42 Through Go/Gβγ Signaling.Front Cell Dev Biol. 2022 Apr 4;10:852738. doi: 10.3389/fcell.2022.852738. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35445022 Free PMC article.
-
Structural biology of cell surface receptors implicated in Alzheimer's disease.Biophys Rev. 2021 Nov 18;14(1):233-255. doi: 10.1007/s12551-021-00903-9. eCollection 2022 Feb. Biophys Rev. 2021. PMID: 35340615 Free PMC article. Review.
-
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects.Front Endocrinol (Lausanne). 2021 Aug 23;12:721135. doi: 10.3389/fendo.2021.721135. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34497589 Free PMC article. Review.
-
A Comprehensive Review of Alzheimer's Association with Related Proteins: Pathological Role and Therapeutic Significance.Curr Neuropharmacol. 2020;18(8):674-695. doi: 10.2174/1570159X18666200203101828. Curr Neuropharmacol. 2020. PMID: 32172687 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
